Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02518022

How to be Safe With Alcoholic Drinks in Diabetes

A Monocentric, Controlled, Randomized, Open-label Cross-over Study to Explore the Possible Insulin Treatment of Beverages Containing Alcohol and Carbohydrates in Adolescents and Young Adults With Type 1 Diabetes

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Kinderkrankenhaus auf der Bult · Academic / Other
Sex
All
Age
16 Years – 21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to show that during and after drinking beer a treatment strategy by insulin bolus and reduction of basal rate reduces the rate of hyperglycaemia without an increase of hypoglycaemic events compared to a treatment strategy according to the standard recommendation without insulin Bolus.

Detailed description

Participants will get two times a height, weight an gender based amount of beer. One time (Standard) there will be no Insulin given for the beer. Second time (Intervention) half of the carbohydrates containing in the beer will be covered with Insulin, additionally the basal rate will be set to 50% for 12 hours. All the time, Glucose will be monitored by continuous subcutaneous Glucose Monitoring.

Conditions

Interventions

TypeNameDescription
DRUGInsulinInsulin for beer

Timeline

Start date
2015-09-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2015-08-07
Last updated
2016-08-04

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02518022. Inclusion in this directory is not an endorsement.